PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8340945-4	1993	PURPOSE: Our purpose was to study, in vitro and in vivo, the antitumor effects of doxorubicin in combination with anti-EGF receptor MAbs against tumor cells expressing high levels of EGF receptor.	Doxorubicin	82-93	epidermal growth factor receptor	Homo sapiens	183-195	
8340945-17	1993	CONCLUSIONS: Our results suggest that anti-EGF receptor MAbs substantially enhance the effects of doxorubicin against well-established xenografts of tumor cells expressing high levels of EGF receptors.	Doxorubicin	98-109	epidermal growth factor receptor	Homo sapiens	43-55